Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the withdrawal of the subsidiary\'s application for drug registration
Wei Xinkang: Announcement on the implementation of equity allocation for the first three quarters of 2024 by Tibet Weixinkang Pharmaceutical Co., Ltd.
Wei Xinkang: Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the consistent evaluation of the quality and efficacy of its subsidiary drugs
Tibet Weixinkang Pharmaceutical Co., Ltd. Equity Distribution Implementation Notice for the First Three Quarters of 2024
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the consistent evaluation of the quality and efficacy of its subsidiary drugs
Weixinkang Investor Relations Activity Record Form (2024-11-05)
Wei Xinkang: Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the progress of share repurchase
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the progress of share repurchase
Weixinkang Investor Relations Activity Record Form (2024-10-31)
Wei Xinkang: Announcement of the profit distribution plan for the first three quarters of 2024 of Tibet Weixinkang Pharmaceutical Co., Ltd.
Wei Xinkang: Report for the Third Quarter of 2024 of Tibet Weixinkang Pharmaceutical Co., Ltd.
Wei Xinkang: Announcement of Resolutions of the 12th Meeting of the Third Board of Directors of Tibet Weixinkang Pharmaceutical Co., Ltd.
Wei Xinkang: Announcement of Resolutions of the 11th Meeting of the Third Board of Supervisors of Tibet Weixinkang Pharmaceutical Co., Ltd.
Wei Xinkang: Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2024
Report for the third quarter of 2024 of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 11th Meeting of the Third Board of Supervisors of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 12th Meeting of the Third Board of Directors of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on holding a performance briefing for the third quarter of 2024
Announcement of the profit distribution plan for the first three quarters of 2024 of Tibet Weixinkang Pharmaceutical Co., Ltd.
Announcement of Tibet Weixinkang Pharmaceutical Co., Ltd. on the consistent evaluation of the quality and efficacy of its subsidiary drugs
No Data
No Data